The next treatment paradigm in cardiovascular prevention?

Journal article

Jennifer G Robinson

The Lancet (British edition), Vol.394(10215), pp.2129-2131

12/14/2019

DOI: 10.1016/S0140-6736(19)32949-6

PMID: 31810608

View Online

no abstract | discussion

Cholesterol

Cardiovascular Diseases

Humans

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Primary Prevention

Risk Factors

Title: Subtitle: The next treatment paradigm in cardiovascular prevention?
Creators: Jennifer G Robinson - Departments of Epidemiology and Internal Medicine, Division of Cardiology, University of Iowa, Iowa City, IA 52242, USA. Electronic address: jennifer-g-robinson@uiowa.edu
Resource Type: Journal article
Publication Details: The Lancet (British edition), Vol.394(10215), pp.2129-2131
DOI: 10.1016/S0140-6736(19)32949-6
PMID: 31810608
ISSN: 0140-6736
eISSN: 1474-547X
Language: English
Date published: 12/14/2019
Academic Unit: Epidemiology; Fraternal Order of Eagles Diabetes Research Center
Record Identifier: 9984363585602771

8 Record Views